Efficacy and safety of once-weekly semaglutide versus once-daily insulin glargine as add-on to metformin (with or without sulfonylureas) in insulin-naive patients with type 2 diabetes (SUSTAIN 4): a randomised, open-label, parallel-group, multicentre, multinational, phase 3a trial
Unlike fad diets or weight loss products, your investment here includes expert care and long-term guidance
Importantly it was not until millions of women had taken the pill over a period of time that researchers began to understand the true nature of their benefits and side effects
Insulin-signaling pathway regulates the degradation of Amyloid beta-protein via Astrocytes
Food & Drug Administration (FDA-a)
All adults had a recorded diagnosis of obesity defined as BMI of 30 kg/m 2 or higher or BMI of 27 kg/m 2 to 29.9 kg/m 2 with at least one weight-related comorbidity